Biofabricated Fatty Acids-Capped Silver Nanoparticles as Potential Antibacterial, Antifungal, Antibiofilm and Anticancer Agents
The current study demonstrates the synthesis of fatty acids (FAs) capped silver nanoparticles (AgNPs) using aqueous poly-herbal drug Liv52 extract (PLE) as a reducing, dispersing and stabilizing agent. The NPs were characterized by various techniques and used to investigate their potent antibacteria...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-02-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/14/2/139 |
| _version_ | 1797412168563425280 |
|---|---|
| author | Mohammad Azam Ansari Sarah Mousa Maadi Asiri Mohammad A. Alzohairy Mohammad N. Alomary Ahmad Almatroudi Firdos Alam Khan |
| author_facet | Mohammad Azam Ansari Sarah Mousa Maadi Asiri Mohammad A. Alzohairy Mohammad N. Alomary Ahmad Almatroudi Firdos Alam Khan |
| author_sort | Mohammad Azam Ansari |
| collection | DOAJ |
| description | The current study demonstrates the synthesis of fatty acids (FAs) capped silver nanoparticles (AgNPs) using aqueous poly-herbal drug Liv52 extract (PLE) as a reducing, dispersing and stabilizing agent. The NPs were characterized by various techniques and used to investigate their potent antibacterial, antibiofilm, antifungal and anticancer activities. GC-MS analysis of PLE shows a total of 37 peaks for a variety of bio-actives compounds. Amongst them, n-hexadecanoic acid (21.95%), linoleic acid (20.45%), oleic acid (18.01%) and stearic acid (13.99%) were found predominately and most likely acted as reducing, stabilizing and encapsulation FAs in LIV-AgNPs formation. FTIR analysis of LIV-AgNPs shows some other functional bio-actives like proteins, sugars and alkenes in the soft PLE corona. The zone of inhibition was 10.0 ± 2.2–18.5 ± 1.0 mm, 10.5 ± 2.5–22.5 ± 1.5 mm and 13.7 ± 1.0–16.5 ± 1.2 against <i>P. aeruginosa</i>, <i>S. aureus</i> and <i>C. albicans</i>, respectively. LIV-AgNPs inhibit biofilm formation in a dose-dependent manner i.e., 54.4 ± 3.1%—10.12 ± 2.3% (<i>S. aureus</i>)<i>,</i> 72.7 ± 2.2%–23.3 ± 5.2% (<i>P. aeruginosa</i>) and 85.4 ± 3.3%–25.6 ± 2.2% (<i>C. albicans</i>), and SEM analysis of treated planktonic cells and their biofilm biomass validated the fitness of LIV-AgNPs in future nanoantibiotics. In addition, as prepared FAs rich PLE capped AgNPs have also exhibited significant (<i>p</i> < 0.05 *) antiproliferative activity against cultured HCT-116 cells. Overall, this is a very first demonstration on employment of FAs rich PLE for the synthesis of highly dispersible, stable and uniform sized AgNPs and their antibacterial, antifungal, antibiofilm and anticancer efficacy. |
| first_indexed | 2024-03-09T04:58:12Z |
| format | Article |
| id | doaj.art-7c7ed62bc98a474d8dc4a02f995032ae |
| institution | Directory Open Access Journal |
| issn | 1424-8247 |
| language | English |
| last_indexed | 2024-03-09T04:58:12Z |
| publishDate | 2021-02-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceuticals |
| spelling | doaj.art-7c7ed62bc98a474d8dc4a02f995032ae2023-12-03T13:03:25ZengMDPI AGPharmaceuticals1424-82472021-02-0114213910.3390/ph14020139Biofabricated Fatty Acids-Capped Silver Nanoparticles as Potential Antibacterial, Antifungal, Antibiofilm and Anticancer AgentsMohammad Azam Ansari0Sarah Mousa Maadi Asiri1Mohammad A. Alzohairy2Mohammad N. Alomary3Ahmad Almatroudi4Firdos Alam Khan5Department of Epidemic Disease Research, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi ArabiaDepartment of Biophysics, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi ArabiaDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Qassim University, Qassim 51431, Saudi ArabiaNational Center for Biotechnology, Life Science and Environmental Research Institute, King Abdulaziz City for Science and Technology, P.O. Box 6086, Riyadh 11451, Saudi ArabiaDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Qassim University, Qassim 51431, Saudi ArabiaDepartment of Stem Cell Biology, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi ArabiaThe current study demonstrates the synthesis of fatty acids (FAs) capped silver nanoparticles (AgNPs) using aqueous poly-herbal drug Liv52 extract (PLE) as a reducing, dispersing and stabilizing agent. The NPs were characterized by various techniques and used to investigate their potent antibacterial, antibiofilm, antifungal and anticancer activities. GC-MS analysis of PLE shows a total of 37 peaks for a variety of bio-actives compounds. Amongst them, n-hexadecanoic acid (21.95%), linoleic acid (20.45%), oleic acid (18.01%) and stearic acid (13.99%) were found predominately and most likely acted as reducing, stabilizing and encapsulation FAs in LIV-AgNPs formation. FTIR analysis of LIV-AgNPs shows some other functional bio-actives like proteins, sugars and alkenes in the soft PLE corona. The zone of inhibition was 10.0 ± 2.2–18.5 ± 1.0 mm, 10.5 ± 2.5–22.5 ± 1.5 mm and 13.7 ± 1.0–16.5 ± 1.2 against <i>P. aeruginosa</i>, <i>S. aureus</i> and <i>C. albicans</i>, respectively. LIV-AgNPs inhibit biofilm formation in a dose-dependent manner i.e., 54.4 ± 3.1%—10.12 ± 2.3% (<i>S. aureus</i>)<i>,</i> 72.7 ± 2.2%–23.3 ± 5.2% (<i>P. aeruginosa</i>) and 85.4 ± 3.3%–25.6 ± 2.2% (<i>C. albicans</i>), and SEM analysis of treated planktonic cells and their biofilm biomass validated the fitness of LIV-AgNPs in future nanoantibiotics. In addition, as prepared FAs rich PLE capped AgNPs have also exhibited significant (<i>p</i> < 0.05 *) antiproliferative activity against cultured HCT-116 cells. Overall, this is a very first demonstration on employment of FAs rich PLE for the synthesis of highly dispersible, stable and uniform sized AgNPs and their antibacterial, antifungal, antibiofilm and anticancer efficacy.https://www.mdpi.com/1424-8247/14/2/139metal nanoparticlesGC-MSFT-IRXRDfatty acidsdrug resistant |
| spellingShingle | Mohammad Azam Ansari Sarah Mousa Maadi Asiri Mohammad A. Alzohairy Mohammad N. Alomary Ahmad Almatroudi Firdos Alam Khan Biofabricated Fatty Acids-Capped Silver Nanoparticles as Potential Antibacterial, Antifungal, Antibiofilm and Anticancer Agents Pharmaceuticals metal nanoparticles GC-MS FT-IR XRD fatty acids drug resistant |
| title | Biofabricated Fatty Acids-Capped Silver Nanoparticles as Potential Antibacterial, Antifungal, Antibiofilm and Anticancer Agents |
| title_full | Biofabricated Fatty Acids-Capped Silver Nanoparticles as Potential Antibacterial, Antifungal, Antibiofilm and Anticancer Agents |
| title_fullStr | Biofabricated Fatty Acids-Capped Silver Nanoparticles as Potential Antibacterial, Antifungal, Antibiofilm and Anticancer Agents |
| title_full_unstemmed | Biofabricated Fatty Acids-Capped Silver Nanoparticles as Potential Antibacterial, Antifungal, Antibiofilm and Anticancer Agents |
| title_short | Biofabricated Fatty Acids-Capped Silver Nanoparticles as Potential Antibacterial, Antifungal, Antibiofilm and Anticancer Agents |
| title_sort | biofabricated fatty acids capped silver nanoparticles as potential antibacterial antifungal antibiofilm and anticancer agents |
| topic | metal nanoparticles GC-MS FT-IR XRD fatty acids drug resistant |
| url | https://www.mdpi.com/1424-8247/14/2/139 |
| work_keys_str_mv | AT mohammadazamansari biofabricatedfattyacidscappedsilvernanoparticlesaspotentialantibacterialantifungalantibiofilmandanticanceragents AT sarahmousamaadiasiri biofabricatedfattyacidscappedsilvernanoparticlesaspotentialantibacterialantifungalantibiofilmandanticanceragents AT mohammadaalzohairy biofabricatedfattyacidscappedsilvernanoparticlesaspotentialantibacterialantifungalantibiofilmandanticanceragents AT mohammadnalomary biofabricatedfattyacidscappedsilvernanoparticlesaspotentialantibacterialantifungalantibiofilmandanticanceragents AT ahmadalmatroudi biofabricatedfattyacidscappedsilvernanoparticlesaspotentialantibacterialantifungalantibiofilmandanticanceragents AT firdosalamkhan biofabricatedfattyacidscappedsilvernanoparticlesaspotentialantibacterialantifungalantibiofilmandanticanceragents |